Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine salvage therapy in relapsed or refractory AML
NCT01295307Phase 2Completed
- Sponsor
- Technische Universität Dresden
- Start
- Mar 2011
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Technische Universität Dresden. Started Mar 2011; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01295307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295307.